‹ All Posts
Capital Investo Research

4th May · SEBI-Registered Analyst

DMART
Q4 Results: ₹656 Crore Profit, Margins Improve; Stock Remains in FocusQ4 Results: ₹656 Crore Profit, Margins Improve; Stock Remains in Focus

The company delivered a mixed performance in the March quarter. While profit came in slightly below expectations, revenue growth remained strong and operating margins showed improvement. Overall, the results reflect a balanced outcome. Profit Below Expectations The company reported a net profit of ₹656.6 crore for the March quarter, which fell short of the market estimate of ₹680 crore. This indicates a slightly weaker performance on the profitability front. Margin Improvement Operating margin improved to 6.85%, compared to 6.42% in the same quarter last year. This suggests better cost control and improved operational efficiency. Key Management Changes During the quarter, the company announced significant management changes. Hitesh Shah has been appointed as Chief Business Officer for Pharmacy and Food Services. Additionally, Director Chandrashekhar Bhave will step down from the board effective May 16, and Ravi Sharma has been appointed as Internal Auditor for FY27. Expansion Continues, Crosses 500 Stores The company continued its expansion strategy and crossed the milestone of 500 stores during FY26, reflecting strong growth momentum. Stock Performance In the last trading session, the stock closed slightly higher at ₹4,614. Over the past one month, it has gained 5.77%, and so far in 2026, it has delivered a return of approximately 24.16%. The company’s market capitalization stands at around ₹2.99 lakh crore. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

#MacroViews#Miscellaneous#StockInNews
956 likes·85 comments